Page last updated: 2024-10-19

phenol and Angiogenesis, Pathologic

phenol has been researched along with Angiogenesis, Pathologic in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Erianin is a representative index component for the quality control of the D."1.62Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. ( Jin, CH; Jin, HL; Jin, X; Li, MY; Ma, J; Piao, LX; Ri, M; Wang, JY; Xing, Y; Xu, GH; Yang, A; Zhang, ZH; Zuo, HX, 2021)
"Erianin is a natural product isolated from Dendrobium chrysotoxum Lindl."1.46Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis. ( Cao, Y; Liu, J; Su, C; Zhang, P, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, J1
Liu, J3
Xu, B1
Cao, Y2
Liang, X1
Wu, F1
Shen, X1
Ma, X1
Yang, A1
Li, MY1
Zhang, ZH1
Wang, JY1
Xing, Y1
Ri, M1
Jin, CH1
Xu, GH1
Piao, LX1
Jin, HL1
Zuo, HX1
Ma, J1
Jin, X1
Su, C1
Zhang, P1

Other Studies

3 other studies available for phenol and Angiogenesis, Pathologic

ArticleYear
Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways.
    Toxicology and applied pharmacology, 2022, 03-01, Volume: 438

    Topics: Afatinib; Animals; Bibenzyls; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; ErbB

2022
Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity.
    Journal of ethnopharmacology, 2021, Jun-12, Volume: 273

    Topics: Adaptor Proteins, Signal Transducing; Animals; B7-H1 Antigen; Bibenzyls; Cell Cycle Proteins; Cell L

2021
Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 88

    Topics: Animals; Bibenzyls; Calibration; Carcinoma, Lewis Lung; Cell Line, Tumor; Human Umbilical Vein Endot

2017